Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |